Association of Placenta Removal Method and Postpartum Leucocytosis
Cesarean Section Complications
About this trial
This is an interventional prevention trial for Cesarean Section Complications focused on measuring Placenta removal method, postpartum leucocytosis, endometritis, postpartum anemia
Eligibility Criteria
Inclusion Criteria:
- Nonanemic pregnancies
- Singleton pregnancies
- Term pregnancies
- Elective cesarean sections
Exclusion Criteria:
- Patients having umbilical cord prolapse,
- Patients having placenta previa
- Patients having preterm rupture of mebranes
- Patients having maternal infection
- Patients having multiple gestation
- Patients having antepartum hemorrhage
- Patients having severe pre-eclampsia
- Patients having placenta previa
- Patients having placental abruption
- Patients having uncontrolled gestational diabetes
- Heart disease
- Liver disorders
- Renal disorders
- Coagulopathy
Sites / Locations
- University of Health Sciences Turkey
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
control group
Study Group
In group 1, plasenta is removed manually. Manual removal of the placenta will be performed by placing surgeon's dominant hand in the uterine cavity and removing the placenta by detaching it from the uterine wall as soon as possible after the delivery of the infant. The emptiness of the uterine cavity is verified manually.
In group 2, plasenta is removed by controlled cord traction. Spontaneous removal will be performed by external uterine massage and traction on the umbilical cord are performed to assist spontaneous delivery of the placenta.